{
    "anthropic.claude-3-5-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "anthropic.claude-3-5-sonnet-v1:0",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Rosuvastatin (Crestor)",
                "Pravastatin (Pravachol)",
                "Lovastatin (Mevacor)",
                "Fluvastatin (Lescol)",
                "Pitavastatin (Livalo)",
                "Ezetimibe (Zetia)",
                "Fenofibrate (Tricor)",
                "Gemfibrozil (Lopid)",
                "Niacin (Niaspan)",
                "Omega-3 fatty acids (Lovaza)",
                "Colesevelam (Welchol)",
                "Cholestyramine (Questran)",
                "Colestipol (Colestid)",
                "Alirocumab (Praluent)",
                "Evolocumab (Repatha)",
                "Bempedoic acid (Nexletol)",
                "Icosapent ethyl (Vascepa)",
                "Lomitapide (Juxtapid)",
                "Mipomersen (Kynamro)",
                "Evinacumab (Evkeeza)",
                "Inclisiran (Leqvio)",
                "Volanesorsen (Waylivra)"
            ]
        }
    ],
    "anthropic.claude-3-opus-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "anthropic.claude-3-opus-v1:0",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Rosuvastatin (Crestor)",
                "Pravastatin (Pravachol)",
                "Lovastatin (Mevacor)",
                "Fluvastatin (Lescol)",
                "Pitavastatin (Livalo)",
                "Cerivastatin (Baycol)",
                "Fenofibrate (Tricor)",
                "Gemfibrozil (Lopid)",
                "Clofibrate (Atromid-S)",
                "Niacin (Niaspan)",
                "Cholestyramine (Questran)",
                "Colestipol (Colestid)",
                "Colesevelam (Welchol)",
                "Ezetimibe (Zetia)",
                "Alirocumab (Praluent)",
                "Evolocumab (Repatha)",
                "Bempedoic acid (Nexletol)",
                "Lomitapide (Juxtapid)",
                "Mipomersen (Kynamro)",
                "Icosapent ethyl (Vascepa)",
                "Omega-3 fatty acids (Lovaza)",
                "Inclisiran (Leqvio)"
            ]
        }
    ],
    "anthropic.claude-3-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "anthropic.claude-3-sonnet-v1:0",
            "response": [
                "Atorvastatin (ATV)",
                "Rosuvastatin (RSV)",
                "Simvastatin (SMV)",
                "Pravastatin (PRV)",
                "Lovastatin (LVA)",
                "Fluvastatin (FLV)",
                "Pitavastatin (PTV)",
                "Ezetimibe (EZE)",
                "Fenofibrate (FNF)",
                "Gemfibrozil (GFZ)",
                "Niacin (NIA)",
                "Cholestyramine (CHO)",
                "Colestipol (CLP)",
                "Colesevelam (CSV)",
                "Evolocumab (EVO)",
                "Alirocumab (ALR)",
                "Bempedoic Acid (BPA)",
                "Inclisiran (INC)",
                "Lomitapide (LMT)",
                "Mipomersen (MIP)",
                "Omega-3 Fatty Acids (OMG)",
                "Plant Stanols/Sterols (PSS)",
                "Red Yeast Rice (RYR)",
                "Psyllium (PSY)"
            ]
        }
    ],
    "anthropic.claude-3-haiku-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "anthropic.claude-3-haiku-v1:0",
            "response": [
                "Atorvastatin (Lipitor)",
                "Fluvastatin (Lescol)",
                "Lovastatin (Mevacor)",
                "Pravastatin (Pravachol)",
                "Rosuvastatin (Crestor)",
                "Simvastatin (Zocor)",
                "Ezetimibe (Zetia)",
                "Fenofibrate (Tricor)",
                "Gemfibrozil (Lopid)",
                "Niacin (Niaspan)",
                "Omega-3 Fatty Acids (Lovaza)",
                "Colesevelam (Welchol)"
            ]
        }
    ],
    "gemma-3": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "gemma-3",
            "response": [
                "Atorvastatin (ATOR)",
                "Simvastatin (SIM)",
                "Rosuvastatin (ROSU)",
                "Pravastatin (PRAV)",
                "Lovastatin (LOV)",
                "Fluvastatin (FLUV)",
                "Pitavastatin (PITA)",
                "Ezetimibe (EZET)",
                "Gemfibrozil (GEM)",
                "Fenofibrate (FENO)",
                "Bezafibrate (BEZA)",
                "Clofibrate (CLOF)",
                "Nicotinic Acid (NIAC)",
                "Omega-3 Fatty Acids (OM3)",
                "Probucol (PROB)",
                "Bempedoic Acid (BEMP)",
                "Inclisiran (INCL)",
                "Lomitapide (LOMI)",
                "Mipomersen (MIPO)",
                "PCSK9 Inhibitors (PCSK9i) - Alirocumab",
                "PCSK9 Inhibitors (PCSK9i) - Evolocumab",
                "CETP Inhibitors - Anacetrapib",
                "CETP Inhibitors - Dalcetrapib",
                "Fibric Acid Derivatives (FADs) - Fenofibric Acid"
            ]
        }
    ],
    "gpt-35-turbo-16k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "gpt-35-turbo-16k",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Rosuvastatin (Crestor)",
                "Pravastatin (Pravachol)",
                "Lovastatin (Mevacor)",
                "Fluvastatin (Lescol)",
                "Pitavastatin (Livalo)",
                "Ezetimibe (Zetia)",
                "Fenofibrate (Tricor)",
                "Gemfibrozil (Lopid)",
                "Niacin (Niaspan)",
                "Omega-3-acid ethyl esters (Lovaza)",
                "Evolocumab (Repatha)",
                "Alirocumab (Praluent)",
                "Bempedoic acid (Nexletol)",
                "Inclisiran (Leqvio)",
                "Colesevelam (Welchol)",
                "Cholestyramine (Questran)",
                "Ezetimibe/simvastatin (Vytorin)",
                "Fenofibrate/rosuvastatin (TriCor/Triglide)",
                "Niacin/simvastatin (Simcor)",
                "Niacin/lovastatin (Advicor)",
                "Omega-3-acid ethyl esters/lovastatin (Omacor/Altoprev)",
                "Omega-3-acid ethyl esters/simvastatin (Vascepa/Zetia)",
                "Omega-3-acid ethyl esters/atorvastatin (Epanova/Lipitor)"
            ]
        }
    ],
    "gpt-4-32k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "gpt-4-32k",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Rosuvastatin (Crestor)",
                "Pravastatin (Pravachol)",
                "Lovastatin (Mevacor)",
                "Fluvastatin (Lescol)",
                "Pitavastatin (Livalo)",
                "Ezetimibe (Zetia)",
                "Niacin (Niaspan)",
                "Fenofibrate (Tricor)",
                "Omega-3 Acid Ethyl Esters (Lovaza)",
                "Colesevelam (Welchol)",
                "Alirocumab (Praluent)",
                "Evacetrapib (LY2484595)",
                "Anacetrapib (MK-0859)",
                "Torcetrapib (CP-529414)",
                "Dalcetrapib (JTT-705)",
                "Gemfibrozil (Lopid)",
                "Colestipol (Colestid)",
                "Cholestyramine (Questran)",
                "Mipomersen (Kynamro)",
                "Lomitapide (Juxtapid)",
                "Evolocumab (Repatha)",
                "Bempedoic Acid (Nexletol)"
            ]
        }
    ],
    "gpt-4o": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "gpt-4o",
            "response": [
                "Atorvastatin (Lipitor)",
                "Rosuvastatin (Crestor)",
                "Simvastatin (Zocor)",
                "Pravastatin (Pravachol)",
                "Lovastatin (Mevacor)",
                "Fluvastatin (Lescol)",
                "Pitavastatin (Livalo)",
                "Ezetimibe (Zetia)",
                "Fenofibrate (Tricor)",
                "Gemfibrozil (Lopid)",
                "Niacin (Niaspan)",
                "Omega-3-acid ethyl esters (Lovaza)",
                "Icosapent ethyl (Vascepa)",
                "Cholestyramine (Questran)",
                "Colestipol (Colestid)",
                "Colesevelam (Welchol)",
                "Alirocumab (Praluent)",
                "Evolocumab (Repatha)",
                "Bempedoic acid (Nexletol)",
                "Lomitapide (Juxtapid)",
                "Mipomersen (Kynamro)",
                "Inclisiran (Leqvio)",
                "Probucol",
                "Ciprofibrate"
            ]
        }
    ],
    "gpt-4o-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "gpt-4o-mini",
            "response": [
                "Atorvastatin (ATOR)",
                "Simvastatin (SIM)",
                "Rosuvastatin (ROSU)",
                "Lovastatin (LOVA)",
                "Pravastatin (PRAV)",
                "Fluvastatin (FLUV)",
                "Niacin (NIAC)",
                "Ezetimibe (EZET)",
                "Fenofibrate (FENO)",
                "Gemfibrozil (GEM)",
                "Alirocumab (ALI)",
                "Evolocumab (EVO)",
                "Bempedoic acid (BEM)",
                "Lomitapide (LOMI)",
                "Mipomersen (MIPO)",
                "Pitavastatin (PITA)",
                "Cilostazol (CILO)",
                "Omega-3-acid ethyl esters (OMEGA)",
                "Caduet (CADU)",
                "Vytorin (VYTO)",
                "Statin class (STAT)",
                "Cholestyramine (CHOLE)",
                "Colesevelam (COLE)",
                "Icosapent ethyl (ICOS)"
            ]
        }
    ],
    "o1-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "o1-mini",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Rosuvastatin (Crestor)",
                "Pravastatin (Pravachol)",
                "Lovastatin (Mevacor)",
                "Fluvastatin (Lescol)",
                "Pitavastatin (Livalo)",
                "Ezetimibe (Zetia)",
                "Fenofibrate (Tricor)",
                "Gemfibrozil (Lopid)",
                "Niacin (Niaspan)",
                "Bempedoic acid (Nexletol)",
                "Alirocumab (Praluent)",
                "Evolocumab (Repatha)",
                "Mipomersen (Kynamro)",
                "Lomitapide (Juxtapid)",
                "Omega-3 fatty acids (Lovaza)",
                "Bezafibrate (Bezalip)",
                "Pemafibrate (Vupanor)",
                "Colesevelam (Welchol)",
                "Icosapent ethyl (Vascepa)",
                "Inclisiran (Leqvio)",
                "Anacetrapib (experimental)",
                "CETP inhibitors (experimental)"
            ]
        }
    ],
    "meta.llama3-70b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "meta.llama3-70b-instruct-v1:0",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Pravastatin (Pravachol)",
                "Fluvastatin (Lescol)",
                "Rosuvastatin (Crestor)",
                "Pitavastatin (Livalo)",
                " Lovastatin (Mevacor)",
                " Cerivastatin (Baycol)",
                " Colesevelam (WelChol)",
                "Cholestyramine (Questran)",
                "Colestipol (Colestid)",
                "Nicotinic acid (Niaspan)",
                "Fenofibrate (Tricor)",
                "Bezafibrate (Bezalip)",
                "Ciprofibrate (Modalim)",
                " Gemfibrozil (Lopid)",
                " Clofibrate (Atromid-S)",
                "Alirocumab (Praluent)",
                "Evolocumab (Repatha)",
                "Bempedoic acid (Nexletol)",
                "colesevelam HBr (WelChol HBr)",
                "bile acid sequestrant (Colestid)",
                "ezetimibe (Zetia)"
            ]
        }
    ],
    "meta.llama3-8b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "meta.llama3-8b-instruct-v1:0",
            "response": [
                "Cholesterol-lowering agent (Atorvastatin)",
                "Cholesterol-lowering agent (Simvastatin)",
                "Cholesterol-lowering agent (Fluvastatin)",
                "Cholesterol-lowering agent (Pravastatin)",
                "Cholesterol-lowering agent (Lovastatin)",
                "Cholesterol-lowering agent (Rosuvastatin)",
                "Cholesterol-lowering agent (Pitavastatin)",
                "Cholesterol-lowering agent (Cerivastatin)",
                "Cholesterol-lowering agent (Fluxastatin)",
                "Cholesterol-lowering agent (Atorvastatin calcium)",
                "Cholesterol-lowering agent (Simvastatin sodium)",
                "Cholesterol-lowering agent (Fluvastatin sodium)",
                "Cholesterol-lowering agent (Pravastatin sodium)",
                "Cholesterol-lowering agent (Lovastatin sodium)",
                "Cholesterol-lowering agent (Rosuvastatin calcium)",
                "Cholesterol-lowering agent (Pitavastatin calcium)",
                "Cholesterol-lowering agent (Cerivastatin sodium)",
                "Cholesterol-lowering agent (Fluxastatin sodium)",
                "Cholesterol-lowering agent (Atorvastatin fumarate)",
                "Cholesterol-lowering agent (Simvastatin acid)",
                "Cholesterol-lowering agent (Fluvastatin acid)",
                "Cholesterol-lowering agent (Pravastatin acid)",
                "Cholesterol-lowering agent (Lovastatin acid)",
                "Cholesterol-lowering agent (Rosuvastatin acid)",
                "Cholesterol-lowering agent (Pitavastatin acid)",
                "Cholesterol-lowering agent (Cerivastatin acid)",
                "Cholesterol-lowering agent (Fluxastatin acid)"
            ]
        }
    ],
    "mistral-small-instruct-24B": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "mistral-small-instruct-24B",
            "response": [
                "Atorvastatin (Lipitor)",
                "Simvastatin (Zocor)",
                "Rosuvastatin (Crestor)",
                "Pravastatin (Pravachol)",
                "Fluvastatin (Lescol)",
                "Lovastatin (Mevacor)",
                "Ezetimibe (Zetia)",
                "Gemfibrozil (Lopid)",
                "Fenofibrate (Tricor)",
                "Bezafibrate (Bezafibrate)",
                "Clofibrate (Atriclor)",
                "Colesevelam (Welchol)",
                "Colestipol (Colestid)",
                "Cholestyramine (Questran)",
                "Niacin (Niaspan)",
                "Alipogene tiparvovec (Glybera)",
                "Evolocumab (Repatha)",
                "Alirocumab (Praluent)",
                "Inclisiran (Leqvio)",
                "Bempegaldesleukin (Bempeg)",
                "Evinacumab (Evkeeza)",
                "Lomitapide (Juxtapid)",
                "Mipomersen (Kynamro)",
                "Ommaritide (Ommaritide)"
            ]
        }
    ],
    "phi-v4": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "phi-v4",
            "response": [
                "Atorvastatin (ATORVASTATIN)",
                "Simvastatin (SIMVASTATIN)",
                "Rosuvastatin (ROSUVASTATIN)",
                "Pravastatin (PRAVASTATIN)",
                "Lovastatin (LOVASTATIN)",
                "Fluvastatin (FLUVASTATIN)",
                "Pitavastatin (PITAVASTATIN)",
                "Ezetimibe (EZETIMIBE)",
                "Ezetimibe/Simvastatin (EZE/SIM)",
                "Ezetimibe/Atorvastatin (EZE/ATOR)",
                "Alirocumab (ALIROCUMAB)",
                "Evolocumab (EVOLOCUMAB)",
                "Bempedoic Acid (BEMPEDOIC ACID)",
                "Lomitapide (Lomitapide)",
                "PCSK9 Inhibitors (PCSK9 INHIBITORS)",
                "Omega-3-acid Ethyl Esters (OMEGA-3-ACID ETHYL ESTERS)",
                "Niacin (NICOTINIC ACID)",
                "Fenofibrate (FENOFIBRATE)",
                "Gemfibrozil (GEMFIBROZIL)",
                "Colesevelam (COLESEVELAM)",
                "Laropiprant (LAROPIPRANT)",
                "Evinacumab (EVINACUMAB)",
                "Bempedoic Acid/PCSK9 Inhibitor Combination (BEMPEDOIC ACID/PCSK9 INHIBITOR COMBINATION)",
                "Mipomersen (MIPOMERSEN)"
            ]
        }
    ],
    "qwen-v2.5-14b-instruct": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been assigned indications for the lowering of serum lipid levels\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for hypercholesterolemia"
            },
            "model": "qwen-v2.5-14b-instruct",
            "response": [
                "Atorvastatin (Atorvastatin)",
                "Rosuvastatin (Rosuvastatin)",
                "Simvastatin (Simvastatin)",
                "Pravastatin (Pravastatin)",
                "Fluvastatin (Fluvastatin)",
                "Lovastatin (Lovastatin)",
                "Pitavastatin (Pitavastatin)",
                "Ezetimibe (Ezetimibe)",
                "Bempedoic acid (Bempedoic acid)",
                "PCSK9 inhibitors (PCSK9 inhibitors)",
                "Niacin (Niacin)",
                "Fenofibrate (Fenofibrate)",
                "Gemfibrozil (Gemfibrozil)",
                "Omega-3 fatty acids (Omega-3 fatty acids)",
                "Cholestyramine (Cholestyramine)",
                "Colestipol (Colestipol)",
                "Elamipretide (Elamipretide)",
                "Lomitapide (Lomitapide)",
                "Mipomersen (Mipomersen)",
                "Apo-A1 Milano (Apo-A1 Milano)",
                "Avasimibe (Avasimibe)",
                "Anacetrapib (Anacetrapib)",
                "Evinacumab (Evinacumab)",
                "Tecfidera (Dimethyl fumarate)"
            ]
        }
    ]
}